Evidence map›Paper›PMID 35426776›Full record

Trial reportAmerican journal of respiratory and critical care medicine2022

Add-On Prostaglandin E

Nina Buchtele, Christian Schörgenhofer, Michael Schwameis, Bernd Jilma, Peter Schellongowski, Harald Herkner, Katharina Riss, Monika Schmid, Alexander Hermann, Oliver Robak and 4 more

Abstract readClinical Trial, Phase IIRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in American journal of respiratory and critical care medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Observational
  5. Review
  6. Review
  7. Between a rock and a hard place: anticoagulation management for ECMO.Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2024
    Review
  8. Review
  9. Review
  10. There Will be Blood-But Maybe Less with Prostaglandin EAmerican journal of respiratory and critical care medicine · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Nina BuchteleDepartment of Medicine I.
Christian SchörgenhoferDepartment of Clinical Pharmacology.
Michael SchwameisDepartment of Emergency Medicine, and.
Bernd JilmaDepartment of Clinical Pharmacology.
Peter SchellongowskiDepartment of Medicine I.
Harald HerknerDepartment of Emergency Medicine, and.
Katharina RissDepartment of Medicine I.
Monika SchmidDepartment of Medicine III, Medical University of Vienna, Vienna, Austria.
Alexander HermannDepartment of Medicine I.
Oliver RobakDepartment of Medicine I.
Bernhard NaglerDepartment of Medicine I.
Ludwig TrabyDepartment of Medicine I.
Andja BojicDepartment of Medicine I.
Thomas StaudingerDepartment of Medicine I.
Medical University of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Extracorporeal Membrane OxygenationAdultAlprostadilDouble-Blind MethodHemorrhageHeparinHumansPilot ProjectsAlprostadilHeparinalprostadilblood coagulationextracorporeal membrane oxygenationplatelet aggregation inhibitorsthromboembolism

Identifiers

PMID35426776
OpenAlexW4223914407

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.